Recombinant anti-tumor and anti-virus protein for injection

· The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Recombinant anti-tumor and anti-virus protein for injection, covering 2016-01-05 to 2016-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer [Phase 2]

See pricing